Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.
University of New South Wales, Sydney NSW 2052, Australia; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Cell Host Microbe. 2020 May 13;27(5):823-829.e3. doi: 10.1016/j.chom.2020.03.006. Epub 2020 Apr 15.
Fecal microbiota transplantation (FMT) targeting gut microbiota has recently been successfully applied to ulcerative colitis. However, only a subset of patients responds to FMT, and there is a pressing need for biomarkers of responsiveness. Fungi (the mycobiota) represent a highly immunologically reactive component of the gut microbiota. We analyzed samples from a large randomized controlled trial of FMT for ulcerative colitis (UC). High Candida abundance pre-FMT was associated with a clinical response, whereas decreased Candida abundance post-FMT was indicative of ameliorated disease severity. High pre-FMT Candida was associated with increased bacterial diversity post-FMT, and the presence of genera was linked to FMT responsiveness. Although we detected elevated anti-Candida antibodies in placebo recipients, this increase was abrogated in FMT recipients. Our data suggest that FMT might reduce Candida to contain pro-inflammatory immunity during intestinal disease and highlight the utility of mycobiota-focused approaches to identify FMT responders prior to therapy initiation.
粪便微生物群移植(FMT)针对肠道微生物群,最近已成功应用于溃疡性结肠炎。然而,只有一部分患者对 FMT 有反应,因此迫切需要反应性生物标志物。真菌(真菌群)是肠道微生物群中具有高度免疫反应性的组成部分。我们分析了来自溃疡性结肠炎(UC)FMT 的大型随机对照试验的样本。FMT 前高假丝酵母菌丰度与临床反应相关,而 FMT 后假丝酵母菌丰度降低则表明疾病严重程度得到改善。FMT 前高假丝酵母菌与 FMT 后细菌多样性增加相关,并且某些属的存在与 FMT 反应性相关。尽管我们在安慰剂组中检测到了升高的抗假丝酵母菌抗体,但在 FMT 组中这种增加被消除了。我们的数据表明,FMT 可能会降低假丝酵母菌以控制肠道疾病中的促炎免疫,并强调了专注于真菌群的方法在治疗前识别 FMT 反应者的实用性。